This month Again we see no changes to the top 3 positions. Montu has risen from seventh to 4th situation, pushing down Specials Pharma, CB1 Medical and Cedarwood. Xeal has also risen right into a labeled situation with the first time. individuals that use medical cannabis items for Serious suffering could have the next risk of coronary heart rhyth